MANKIND PHARMA LTD in the news
Affordable, innovative pharmaceutical products
Tamtam found 20 recent articles about MANKIND PHARMA LTD.
- Technical picks: ABB India among 5 stocks to buy this week for healthy returns
Mankind Pharma's stock has surged past its resistance level of 2638 with high volumes, indicating a potential upward trend and strength across various timeframes.
- Mankind Pharma secures exclusive India rights for Ensartinib from Betta Pharmaceuticals
Mankind Pharma secured exclusive Indian rights for Ensartinib from Betta Pharmaceuticals, an oncology drug for ALK-positive non-small cell lung cancer.
- Trade Spotlight: How should you trade Canara Bank, Mankind Pharma, Amara Raja Energy, Bharat Dynamics,...
Experts recommended seven buy ideas for short-term trading, including Canara Bank, Amara Raja Energy and Mobility, Havells India, Abbott India, Mankind Pharma, National Aluminium Company, Bharat Dynamics, and Larsen and Toubro, based on technical analysis and bullish indicators.
- Stocks to BUY, SELL or HOLD Today, October 27: Paytm, Tata Consumer Products, Mankind Pharma, Urban Company and others
Brokerage firms provided buy, sell, or hold recommendations and updated target prices for various stocks, including Mankind Pharma, on October 27.
- तिमाही नतीजों के बाद इस फार्म स्टॉक में तूफ़ानी तेजी, Kotak को 21% उछाल की उम्मीद, जानें दूसरे ब्रोकरेज की राय
Mankind Pharma's shares surged over 9% following strong Q2 results, with a 39.2% profit increase and 17.3% revenue growth, leading to varied brokerage ratings.
- Mankind Pharma's quarterly profit jumps 39% on strong chronic drug demand
Mankind Pharma's second-quarter profit surged by 39% due to robust demand for chronic disease treatments.
- Mankind Pharma Q2 Results: मैनकाइंड फार्मा का मुनाफा 39% बढ़कर ₹711 करोड़ हुआ, EBITDA मार्जिन 27% पर पहुंचा
Mankind Pharma reported a 39% increase in Q2 FY27 net profit to ₹711 crore and a 17% revenue growth to ₹4,338 crore, with improved EBITDA margins.
- Q2 Results Today, October 26: Paytm, Tata Consumer, Mankind Pharma, REC, Bank of Maharashtra among 80+ companies announcing earnings
More than 90 companies, including Paytm, Tata Consumer Products, and Mankind Pharma, are scheduled to announce their Q2 FY27 earnings on October 26, 2026.
- Q2 Results Monday: Tata Consumer, Paytm, Mankind Pharma among 55 companies to announce earnings on October 26
55 companies, including major players like Tata Consumer, Paytm, and Mankind Pharma, will release their Q2 earnings on October 26, providing insights into various sector performances.
- Stocks to Watch Today, October 16: Mankind Pharma, Maruti Suzuki, Nestle India, Tech Mahindra, Wipro in focus
Mankind Pharma plans a significant acquisition, Maruti Suzuki gets a large tax relief, and several companies, including Nestle India and Tech Mahindra, report their Q2 earnings.
- Mankind Pharma (NSE:MANKIND): What Is Behind Its Q2 and H1 FY27 Earnings Call?
Mankind Pharma announced an earnings conference call on October 26, 2026, to discuss its Q2 and H1 FY27 business and financial results.
- Mankind Pharma Ltd. Share Price Today - Mankind Pharma Ltd. Stock Price Live NSE/BSE
Mankind Pharma Ltd.'s stock price decreased by 1.38% to Rs. 2,367.00, with a market capitalization of Rs. 97,716.47.
- MANKIND: Debt Was The Drag, Chronic And Biologics Now Lead The Upside
Mankind Pharma is focusing on chronic and biologics revenue, international expansion, and deleveraging while seeing a slight increase in fair value.
- Mankind Pharma, Zydus Lifesciences among top losers, fall up to 3% after Supreme Court asks Centre to...
Shares of pharmaceutical companies dropped after the Supreme Court directed the Centre to form a committee to investigate the need for statutory regulation to curb unethical practices by drug companies.
- Mankind Pharma Ltd is Rated Hold by MarketsMOJO
Mankind Pharma Ltd is rated 'Hold' by MarketsMOJO due to strong quality and financial growth, balanced against an expensive valuation.
- Stock of the day - Mankind Pharma Ltd Target Rs. 2720 - Religare Broking Ltd
Mankind Pharma Ltd is showing a bullish trend with a breakout from consolidation, reclaiming moving averages, and forming higher highs and lows, suggesting buying interest.
- Buy BHEL, Mankind Pharma; sell Asian Paints, PNB, Tata Steel: Experts' trading calls
Market experts Shivangi Sarda and Mitessh Thakkar provided short-term stock recommendations, suggesting buying BHEL and Mankind Pharma, and selling Asian Paints, PNB, and Tata Steel.
- 'No amount of money can ever equal...': Mankind Pharma honours Flydubai pilot Captain Smit Machchhar with Rs 1 crore for 'extraordinary courage'
Mankind Pharma honored Captain Smit Machchhar with 1 crore rupees for his courage and leadership during a mid-air altercation on a Flydubai flight, preventing a potential plane crash.
- Delhi High Court protects Mankind Pharma’s “KIND” formative marks against deceptively similar pharmaceutical marks
The Delhi High Court issued an injunction protecting Mankind Pharma Ltd.'s "KIND" formative pharmaceutical trademarks against deceptively similar marks used by another party.
- Mankind Pharma Share Price News: Price Rise and Valuation
Mankind Pharma's share price increased by 2.19% to Rs 2,483 today, reaching a market capitalization of Rs 95,743.85 crore.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like MANKIND PHARMA LTD?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies